What is POCI's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for POCI.

Stock Ratings / Health Care / POCI / options

ECOR (29) OM (34) HYPR (38) QTI (29) ⌘ Pro Terminal →

Precision Optics Corporation Inc. (POCI) Options Positioning, Max Pain & Unusual Sweeps

$4.65 +1.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.65

Precision Optics Corporation Inc. (POCI) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $51.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on POCI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is POCI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Precision Optics Corporation Inc. (NASDAQ: POCI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $4.65 (+1.31% 1D, market cap $51.1M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, POCI ranks #768 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does POCI compare to ECOR and OM in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), POCI carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 17.8%, and ROIC of -35.0%. By comparison, ECOR (electroCore Inc.) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $67.8M) and OM (Outset Medical Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -28.0%, cap $75.8M). Among the 5-stock peer group, POCI leads on earnings multiple (N/A) while OM leads on capital efficiency (-28.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for POCI?

▼

Per POCI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000867840), Precision Optics Corporation Inc. generated $19.1M in revenue (-0.1% YoY), -$5.8M in net income, and -$3.6M in free cash flow against $22.9M in total assets and $1.0M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $4.65 (+0.05%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-12% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for POCI)Realized 20D OHLCV Swing Band: ±8.3%

Deterministic 5-Pillar Attribution (31/100 Composite)

🔍 WHY POCI SCORES 31/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+11/20 pts (35% of score)

FRED Regime × Technicals: 42% of 52W Range • RSI-14 at 59.5 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (32% of score)

20D Institutional Volume Accumulation (±8.3% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$4.56-6.6% Next Q

Q2 (-2Q)

Grade E$4.26+3.5% Next Q

Q3 (-1Q)

Grade E$4.41+5.4% Next Q

Current

Grade E$4.65-9.4% Hist 90D α

Trajectory: E (23) → E (31)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a POCI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While POCI currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.42) and Max Pain ($4.88) forces dealer call-delta covering toward $6.46.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $POCI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “POCI Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 31%NO 69%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±8.3%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (POCI)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for POCI.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring POCI)

✓Walkthrough of POCI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

POCI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +9.93%⚡ TESTING RESISTANCE

2026-11-03O $4.59H $4.65L $4.59C $4.65VOL 11.3K

RES: $4.63SUP: $4.01SMA50: $4.42SMA200: $4.63

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

POCI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 POCI Butterfly Map → + Track POCI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -0.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on POCI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for POCI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for POCI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (POCI)

Health Care Rank #768 of 1016 ⚔️ ECOR vs POCI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (POCI vs. ECOR, OM, HYPR, QTI)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Precision Optics Corporation Inc. (POCI) ranks #768 by composite RQD confidence (31/100, grade E) and #743 by equity capitalization ($51.1M). Within this direct 5-issuer industry benchmark cohort, POCI leads on earnings valuation at N/A trailing P/E, while OM leads on capital efficiency and profitability with -28.0% ROIC and 39.1% gross margin. HYPR currently holds the highest overall quantitative score in the immediate peer group at 38/100 (D-) compared with POCI at 31/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
POCI ACTIVE Precision Optics Corporation Inc.	E	31/100	—	17.8%	-35.0%	+1.31%	$51.1M	Benchmark Subject
ECOR electroCore Inc.	E	29/100	—	86.8%	-35.0%	-7.27%	$67.8M	/ecor-vs-poci →
OM Outset Medical Inc.	E	34/100	—	39.1%	-28.0%	-3.82%	$75.8M	/om-vs-poci →
HYPR Hyperfine Inc. (Class A)	D-	38/100	—	49.8%	-35.0%	-3.50%	$76.1M	/hypr-vs-poci →
QTI QT Imaging Holdings Inc.	E	29/100	—	45.4%	-35.0%	-3.17%	$31.3M	/qti-vs-poci →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0000867840

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Precision Optics Corporation Inc. (POCI) reported GAAP revenue of $19.1M (-0.1% vs. FY2024 revenue of $19.1M , and -9.3% cumulative change since FY2023) , GAAP net income of -$5.8M, operating cash flow of -$3.4M, and free cash flow of -$3.6M (-22.6% YoY). On the balance sheet, POCI closed FY2025 with $22.9M in total assets against $1.0M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$19.1M	-$5.8M	-$3.4M	-$3.6M	$22.9M	$1.0M
FY2024 (FY)	2024-06-30	$19.1M	-$3.0M	-$2.7M	-$3.0M	$17.5M	$1.6M
FY2023 (FY)	2023-06-30	$21.0M	-$144.6K	-$81.1K	-$81.1K	—	—

3. POCI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is POCI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does POCI compare to ECOR and OM in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for POCI?

Where is POCI trading relative to its 50-day, 200-day, and 52-week technical levels?

POCI last traded at $4.65 (+1.31% on volume of 11,253 shares), positioning the stock +5.20% above its 50-day simple moving average ($4.42) and +0.43% above its 200-day simple moving average ($4.63). Across its 52-week range of $3.55 to $6.15, POCI sits at the 42.3% percentile with a 14-day RSI of 59.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.3% ($4.26 to $5.04).

Direct Sub-Reports: POCI RQD Cockpit POCI 12M Forecast POCI Earnings & Move POCI Dividends & DRIP POCI Insiders & 13F POCI Whale Options POCI Profit Sankey POCI News & Why

ROARABLE RATING BRIEF • RQD 31/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

POCI — Precision Optics Corporation Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:46:55Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, POCI scores 28 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are: Fundamental Cash Engine at 5/20 (reflecting ROIC of -35% and FCF yield of -7.18%); Whale 13F Flow at 10/20 (institutional accumulation and options positioning); Insider Conviction at 3/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 8/20 (Beta 1.0, sector sensitivity); and Forensic Balance Sheet at 2/20 (Altman Z 0.2, Piotroski F 3/9, Debt/Equity 0.11). For a prospective investor, the weakest pillars are the forensic balance sheet and insider conviction, which weigh against any upside thesis. The highest-scoring pillar, institutional flow, is the only one suggesting some market support, but it does not offset negative cash generation and a Z-Score in the distress range.

Recent Catalysts & News Wire Analysis

Per the recent news section, the feed contains five items, all tied to POCI. Two are YELLOW-tagged market wire items (a Yahoo Finance seasonal returns chart and a Stock Titan profile page) with no substantive content in the summaries. A Investing.com item reports a new one-year lease for a Gardner, MA facility, tagged YELLOW. A Stock Titan item on CEO pay of $381K as part of an advisory executive pay vote is tagged RED under RISK WATCH. A feed item headlined as POCI edging lower to $4.32 is tagged GREEN under CATALYST, though its summary field references an unrelated domain and should be treated as unverified. Per the butterfly supply-chain graph, the supply chain is NONE with no butterfly links and no proprietary signals.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is NONE, with no upstream or downstream links and no proprietary signals recorded. Investors should note that the absence of mapped links means no ripple effects can be traced from the source data.

Open Questions

What are POCI's specific products, customers, and revenue drivers, given that the source data describes only sector and industry classification?
Why are P/E, EV/EBITDA, and EPS (TTM) unavailable, and what do earnings-based multiples look like once reported?
How will the cash position of $0.9M against $1.0M of debt be funded over the next reporting cycle, and what financing or dilution risk exists?
What drove the widening losses from FY 2023 to FY 2025 while revenue remained near $19.1M?
What is the nature of the Gardner, MA lease and the CEO pay vote, and do they signal any change in operating scale?

POCI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Precision Optics Corporation Inc. (POCI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to POCI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 19h ago

Precision Optics Corporation, Inc. (POCI) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada report covering Precision Optics Corporation Inc. (POCI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 22h ago

Precision Optics Corporation (POCI) Stock Price, News & Analysis

Stock Titan report covering Precision Optics Corporation Inc. (POCI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com South Africa • 1d ago

Precision Optics signs new one-year lease for Gardner, MA facility By Investing.com

Investing.com South Africa report covering Precision Optics Corporation Inc. (POCI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Titan • 1d ago

CEO pay of $381K is part of the advisory executive pay vote at Precision Optics (POCI).

Stock Titan report covering Precision Optics Corporation Inc. (POCI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST https://www.dars.gov.et/ • 1d ago

Precision Optics (POCI) Edges Lower to $4.32 as Shares Consolidate Below Resistance - Earnings Beat Stocks

https://www.dars.gov.et/ report covering Precision Optics Corporation Inc. (POCI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 34d ago

Precision Optics Corp Inc (POCI) (Q4 2026) Earnings Call Highlights: Record Revenue and ...

Yahoo Finance coverage on POCI stock catalysts, institutional flow, and earnings outlook.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 34d ago

Precision Optics Corporation, Inc. Q4 2026 Earnings Call Summary

Moby summary of Precision Optics Corporation, Inc.'s Q4 2026 earnings call

Read Full Source ↗

🔴 RISK WATCH Yahoo Finance • 34d ago

Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference

LITTLETON, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

POCI Bull vs. Bear Conversation Board — What's Your Call at $4.65?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON POCI 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $4.04 (-12.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is POCI (E • RQD 28/100) a Buy at $4.59?

Welcome to the POCI (Precision Optics Corporation Inc.) Roar Pit. Current RQD Composite is 28/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Biotechnology: Electromedical & Electrotherapeutic Apparatus. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $3.44 (-25.1%)

Spot @ $4.59

Pump the brakes on POCI — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on POCI, but look at what you are paying: current EV/EBITDA multiples with 17.8% gross margins. Unless Precision Optics Corporation Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader 🐂 BULLISH 🎯 Target: $5.88 (+28.1%)

Spot @ $4.59

POCI cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on POCI, the market is fixating on short-term headline noise in Biotechnology: Electromedical & Electrotherapeutic Apparatus and ignoring the balance sheet and cash flow trajectory. At $4.59 (52-wk range $3.55 - $6.15), any beat on forward guidance forces shorts and underweight funds to chase.